REFERENCES
- Section 6—mechanical bioeffects in the presence of gas-carrier ultrasound contrast agents. American Institute of Ultrasound in Medicine. J Ultrasound Med 2000; 19: 120–168, [No authors listed][CSA]
- Akowuah E F, Gray C, Lawrie A, Sheridan P J, Su C H, Bettinger T, Brisken A F, Gunn J, Crossman D C, Francis S E, Baker A H, Newman C M. Ultrasound-mediated delivery of TIMP-3 plasmid DNA into saphenous vein leads to increased lumen size in a porcine interposition graft model. Gene Ther 2005; 12: 1154–1157, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Aoyama T, Hosseinkhani H, Yamamoto S, Ogawa O, Tabata Y. Enhanced expression of plasmid DNA-cationized gelatin complex by ultrasound in murine muscle. J Control Release 2002; 80: 345–356, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Apfel R E. Acoustic cavitation: a possible consequence of biomedical uses of ultrasound. Br J Cancer Suppl 1982; 45: 140–146, [PUBMED], [INFOTRIEVE], [CSA]
- Ay T, Havaux X, Van Camp G, Campanelli B, Gisellu G, Pasquet A, Denef J F, Melin J A, Vanoverschelde J L. Destruction of contrast microbubbles by ultrasound: effects on myocardial function, coronary perfusion pressure, and microvascular integrity. Circulation 2001; 104: 461–466, [PUBMED], [INFOTRIEVE], [CSA]
- Azuma H, Tomita N, Kaneda Y, Koike H, Ogihara T, Katsuoka Y, Morishita R. Transfection of NFkappaB-decoy oligodeoxynucleotides using efficient ultrasound-mediated gene transfer into donor kidneys prolonged survival of rat renal allografts. Gene Ther 2003; 10: 415–425, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bao S, Thrall B D, Miller D L. Transfection of a reporter plasmid into cultured cells by sonoporation in vitro. Ultrasound Med Biol 1997; 23: 953–959, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bekeredjian R, Chen S, Frenkel P A, Grayburn P A, Shohet R V. Ultrasound-targeted microbubble destruction can repeatedly direct highly specific plasmid expression to the heart. Circulation 2003; 108: 1022–1026, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bekeredjian R, Chen S, Grayburn P A, Shohet R V. Augmentation of cardiac protein delivery using ultrasound targeted microbubble destruction. Ultrasound Med Biol 2005; 31: 687–691, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bekeredjian R, Chen S, Pan W, Grayburn P A, Shohet R V. Effects of ultrasound-targeted microbubble destruction on cardiac gene expression. Ultrasound Med Biol 2004; 30: 539–543, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bekeredjian R, Grayburn P A, Shohet R V. Use of ultrasound contrast agents for gene or drug delivery in cardiovascular medicine. J Am Coll Cardiol 2005; 45: 329–335, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bian A N, Gao Y H, Tan K B, Liu P, Zeng G J, Zhang X, Liu Z. Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties. World J Gastroenterol 2004; 10: 3424–3427, [PUBMED], [INFOTRIEVE], [CSA]
- Blomley M J, Cooke J C, Unger E C, Monaghan M J, Cosgrove D O. Microbubble contrast agents: a new era in ultrasound. BMJ 2001; 322: 1222–1225, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Borges A C, Walde T, Reibis R K, Grohmann A, Ziebig R, Rutsch W, Schimke I, Baumann G. Does contrast echocardiography with Optison induce myocardial necrosis in humans?. J Am Soc Echocardiogr 2002; 15: 1080–1086, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bouakaz A, Versluis M, De Jong N. High-speed optical observations of contrast agent destruction. Ultrasound Med Biol 2005; 31: 391–399, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Bull J L. Cardiovascular bubble dynamics. Crit Rev Biomed Eng 2005; 33: 299–346, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chappell J C, Klibanov A L, Price R J. Ultrasound-microbubble induced neovascularization in mouse skeletal muscle. Ultrasound Med Biol 2005; 31: 1411–1422, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chen S, Shohet R V, Bekeredjian R, Frenkel P, Grayburn P A. Optimization of ultrasound parameters for cardiac gene delivery of adenoviral or plasmid deoxyribonucleic acid by ultrasound-targeted microbubble destruction. J Am Coll Cardiol 2003; 42: 301–308, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chien C T, Burns P N. Investigation of the effects of microbubble shell disruption on population scattering and implications for modeling contrast agent behavior. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51: 286–292, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Chomas J E, Dayton P, Allen J, Morgan K, Ferrara K W. Mechanisms of contrast agent destruction. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48: 232–248, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Christiansen J P, French B A, Klibanov A L, Kaul S, Lindner J R. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med Biol 2003; 29: 1759–1767, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Cui W, Bei J, Wang S, Zhi G, Zhao Y, Zhou X, Zhang H, Xu Y. Preparation and evaluation of poly(8 8 L-lactide-co-glycolide) (PLGA) microbubbles as a contrast agent for myocardial contrast echocardiography. J Biomed Mater Res B Appl Biomater 2005; 73: 171–178, [PUBMED], [INFOTRIEVE], [CSA]
- Dalecki D. Mechanical bioeffects of ultrasound. Annu Rev Biomed Eng 2004; 6: 229–248, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dalecki D, Child S Z, Raeman C H, Xing C, Gracewski S, Carstensen E L. Bioeffects of positive and negative acoustic pressures in mice infused with microbubbles. Ultrasound Med Biol 2000; 26: 1327–1332, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Danialou G, Comtois A S, Dudley R W, Nalbantoglu J, Gilbert R, Karpati G, Jones D H, Petrof B J. Ultrasound increases plasmid-mediated gene transfer to dystrophic muscles without collateral damage. Mol Ther 2002; 6: 687–693, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dayton P A, Morgan K E, Allietta M, Klibanov A L, Brandenburger G H, Ferrara K W. Simultaneous optical and acoustical observations of contrast agents. IEEE Ultrasonics Symposium 1997; 1583–1591, [CSA]
- Dayton P A, Morgan K E, Klibanov A L, Brandenburger G H, Ferrara K W. Optical and acoustical observations of the effects of ultrasound on contrast agents. IEEE Trans Ultrason Ferroelectr Freq Control 1999; 46: 220–232, [CROSSREF], [CSA]
- Deng C X, Sieling F, Pan H, Cui J. Ultrasound-induced cell membrane porosity. Ultrasound Med Biol 2004; 30: 519–526, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Dijkmans P A, Juffermans L J, Musters R J, Van Wamel A, Ten Cate F J, Van Gilst W, Visser C A, De Jong N, Kamp O. Microbubbles and ultrasound: from diagnosis to therapy. Eur J Echocardiogr 2004; 5: 245–256, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Domkowski P W, Biswas S S, Steenbergen C, Lowe J E. Histological evidence of angiogenesis 9 months after transmyocardial laser revascularization. Circulation 2001; 103: 469–471, [PUBMED], [INFOTRIEVE], [CSA]
- El Sherif D M, Lathia J D, Le N T, Wheatley M A. Ultrasound degradation of novel polymer contrast agents. J Biomed Mater Res A 2004; 68: 71–78, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Endoh M, Koibuchi N, Sato M, Morishita R, Kanzaki T, Murata Y, Kaneda Y. Fetal gene transfer by intrauterine injection with microbubble-enhanced ultrasound. Mol Ther 2002; 5: 501–508, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Enomoto S, Yoshiyama M, Omura T, Matsumoto R, Kusuyama T, Nishiya D, Izumi Y, Akioka K, Iwao H, Takeuchi K, Yoshikawa J. Microbubble destruction with ultrasound augments neovascularization by bone marrow cell transplantation in rat hindlimb ischemia. Heart. Epub. 2005, [CSA]
- Erikson J M, Freeman G L, Chandrasekar B. Ultrasound-targeted antisense oligonucleotide attenuates ischemia/reperfusion-induced myocardial tumor necrosis factor-alpha. J Mol Cell Cardiol 2003; 35: 119–130, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Feinstein S B. The powerful microbubble: from bench to bedside, from intravascular indicator to therapeutic delivery system, and beyond. Am J Physiol Heart Circ Physiol 2004; 287: H450–H457, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Frenkel P A, Chen S, Thai T, Shohet R V, Grayburn P A. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med Biol 2002; 28: 817–822, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Goldberg R F, Fass A E, Frishman W H. Transmyocardial revascularization: defining its role. Cardiol Rev 2005; 13: 52–55, [PUBMED], [INFOTRIEVE], [CSA]
- Gramiak R, Shah P M. Echocardiography of the aortic root. Invest Radiol 1968; 3: 356–366, [PUBMED], [INFOTRIEVE], [CSA]
- Greenleaf W J, Bolander M E, Sarkar G, Goldring M B, Greenleaf J F. Artificial cavitation nuclei significantly enhance acoustically induced cell transfection. Ultrasound Med Biol 1998; 24: 587–595, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Guo D P, Li X Y, Sun P, Wang Z G, Chen X Y, Chen Q, Fan L M, Zhang B, Shao L Z, Li X R. Ultrasound/microbubble enhances foreign gene expression in ECV304 cells and murine myocardium. Acta Biochim Biophys Sin (Shanghai) 2004; 36: 824–831, [CSA]
- Hashiya N, Aoki M, Tachibana K, Taniyama Y, Yamasaki K, Hiraoka K, Makino H, Yasufumi K, Ogihara T, Morishita R. Local delivery of E2F decoy oligodeoxynucleotides using ultrasound with microbubble agent (Optison) inhibits intimal hyperplasia after balloon injury in rat carotid artery model. Biochem Biophys Res Commun 2004; 317: 508–514, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hauff P, Reinhardt M, Briel A, Debus N, Schirner M. Molecular targeting of lymph nodes with 88 L-selectin ligand-specific US contrast agent: a feasibility study in mice and dogs. Radiology 2004; 231: 667–673, [PUBMED], [INFOTRIEVE], [CSA]
- Holland C K, Deng C X, Apfel R E, Alderman J L, Fernandez L A, Taylor K J. Direct evidence of cavitation in vivo from diagnostic ultrasound. Ultrasound Med Biol 1996; 22: 917–925, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Horvath K A, Chiu E, Maun D C, Lomasney J W, Greene R, Pearce W H, Fullerton D A. Up-regulation of vascular endothelial growth factor mRNA and angiogenesis after transmyocardial laser revascularization. Ann Thorac Surg 1999; 68: 825–829, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hu Y, Qin S, Jiang Q. Characteristics of acoustic scattering from a double-layered micro shell for encapsulated drug delivery. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51: 809–821, [PUBMED], [INFOTRIEVE], [CSA]
- Huang S L, MacDonald R C. Acoustically active liposomes for drug encapsulation and ultrasound-triggered release. Biochim Biophys Acta 2004; 1665: 134–141, [PUBMED], [INFOTRIEVE], [CSA]
- Hughes G C, Biswas S S, Yin B, Baklanov D V, Annex B H, Coleman R E, De Grado T R, Landolfo C K, Landolfo K P, Lowe J E. A comparison of mechanical and laser transmyocardial revascularization for induction of angiogenesis and arteriogenesis in chronically ischemic myocardium. J Am Coll Cardiol 2002; 39: 1220–1228, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hughes G C, Lowe J E, Kypson A P, St Louis J D, Pippen A M, Peters K G, Coleman R E, De Grado T R, Donovan C L, Annex B H, Landolfo K P. Neovascularization after transmyocardial laser revascularization in a model of chronic ischemia. Ann Thorac Surg 1998; 66: 2029–2036, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Hwang J H, Brayman A A, Reidy M A, Matula T J, Kimmey M B, Crum L A. Vascular effects induced by combined 1-MHz ultrasound and microbubble contrast agent treatments in vivo. Ultrasound Med Biol 2005; 31: 553–564, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kaul S. Myocardial contrast echocardiography: basic principles. Prog Cardiovasc Dis 2001; 44: 1–11, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Keller M W, Feinstein S B, Watson D D. Successful left ventricular opacification following peripheral venous injection of sonicated contrast agent: an experimental evaluation. Am Heart J 1987; 114: 570–575, [PUBMED], [INFOTRIEVE], [CSA]
- Kinoshita M, Hynynen K. Intracellular delivery of Bak BH3 peptide by microbubble-enhanced ultrasound. Pharm Res 2005; 22: 716–720, [PUBMED], [INFOTRIEVE], [CSA]
- Klibanov A L. Targeted delivery of gas-filled microspheres, contrast agents for ultrasound imaging. Adv Drug Deliv Rev 1999; 37: 139–157, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Koike H, Tomita N, Azuma H, Taniyama Y, Yamasaki K, Kunugiza Y, Tachibana K, Ogihara T, Morishita R. An efficient gene transfer method mediated by ultrasound and microbubbles into the kidney. J Gene Med 2005; 7: 108–116, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kondo I, Ohmori K, Oshita A, Takeuchi H, Fuke S, Shinomiya K, Noma T, Namba T, Kohno M. Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a “functional” gene using ultrasonic microbubble destruction. J Am Coll Cardiol 2004; 44: 644–653, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Kondo T, Misik V, Riesz P. Effect of gas-containing microspheres and echo contrast agents on free radical formation by ultrasound. Free Radic Biol Med 1998; 25: 605–612, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Korpanty G, Chen S, Shohet R V, Ding J, Yang B, Frenkel P A, Grayburn P A. Targeting of VEGF-mediated angiogenesis to rat myocardium using ultrasonic destruction of microbubbles. Gene Ther 2005; 12: 1305–1312, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Krasovitski B, Kimmel E. Shear stress induced by a gas bubble pulsating in an ultrasonic field near a wall. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51: 973–979, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lan H Y, Mu W, Tomita N, Huang X R, Li J H, Zhu H J, Morishita R, Johnson R J. Inhibition of renal fibrosis by gene transfer of inducible Smad7 using ultrasound-microbubble system in rat UUO model. J Am Soc Nephrol 2003; 14: 1535–1548, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lawrie A, Brisken A F, Francis S E, Cumberland D C, Crossman D C, Newman C M. Microbubble-enhanced ultrasound for vascular gene delivery. Gene Ther 2000; 7: 2023–2027, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Li P, Armstrong W F, Miller D L. Impact of myocardial contrast echocardiography on vascular permeability: comparison of three different contrast agents. Ultrasound Med Biol 2004; 30: 83–91, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Li P, Cao L Q, Dou C Y, Armstrong W F, Miller D. Impact of myocardial contrast echocardiography on vascular permeability: an in vivo dose response study of delivery mode, pressure amplitude and contrast dose. Ultrasound Med Biol 2003; 29: 1341–1349, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lindner J R. Evolving applications for contrast ultrasound. Am J Cardiol 2002; 90(Suppl 10A)72J–80J, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lindner J R. Molecular imaging with contrast ultrasound and targeted microbubbles. J Nucl Cardiol 2004; 11: 215–221, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lindner J R, Ismail S, Spotnitz W D, Skyba D M, Jayaweera A R, Kaul S. Albumin microbubble persistence during myocardial contrast echocardiography is associated with microvascular endothelial glycocalyx damage. Circulation 1998; 98: 2187–2194, [PUBMED], [INFOTRIEVE], [CSA]
- Lindner J R, Kaul S. Delivery of drugs with ultrasound. Echocardiography 2001; 18: 329–337, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Lu Q L, Liang H D, Partridge T, Blomley M J. Microbubble ultrasound improves the efficiency of gene transduction in skeletal muscle in vivo with reduced tissue damage. Gene Ther 2003; 10: 396–405, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Manome Y, Nakayama N, Nakayama K, Furuhata H. Insonation facilitates plasmid DNA transfection into the central nervous system and microbubbles enhance the effect. Ultrasound Med Biol 2005; 31: 693–702, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Massett M P, Berk B C. Strain-dependent differences in responses to exercise training in inbred and hybrid mice. Am J Physiol Regul Integr Comp Physiol 2005; 288: R1006–R1013, [PUBMED], [INFOTRIEVE], [CSA]
- Mayer S, Grayburn P A. Myocardial contrast agents: recent advances and future directions. Prog Cardiovasc Dis 2001; 44: 33–44, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Meltzer R S, Tickner E G, Sahines T P, Popp R L. The source of ultrasound contrast effect. J Clin Ultrasound 1980; 8: 121–127, [PUBMED], [INFOTRIEVE], [CSA]
- Miao C H, Brayman A A, Loeb K R, Ye P, Zhou L, Mourad P, Crum L A. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005; 16: 893–905, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miller D L, Gies R A. Gas-body-based contrast agent enhances vascular bioeffects of 1.09 MHz ultrasound on mouse intestine. Ultrasound Med Biol 1998; 24: 1201–1208, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miller D L, Quddus J. Diagnostic ultrasound activation of contrast agent gas bodies induces capillary rupture in mice. Proc Natl Acad Sci USA 2000; 97: 10179–10184, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Miller M W. Gene transfection and drug delivery. Ultrasound Med Biol 2000; 26(Suppl 1)S59–S62, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mitragotri S. Healing sound: the use of ultrasound in drug delivery and other therapeutic applications. Nat Rev Drug Discov 2005; 4: 255–260, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Morawski A M, Lanza G A, Wickline S A. Targeted contrast agents for magnetic resonance imaging and ultrasound. Curr Opin Biotechnol 2005; 16: 89–92, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mukherjee D, Wong J, Griffin B, Ellis S G, Porter T, Sen S, Thomas J D. Ten-fold augmentation of endothelial uptake of vascular endothelial growth factor with ultrasound after systemic administration. J Am Coll Cardiol 2000; 35: 1678–1686, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Mulvagh S L, De Maria A N, Feinstein S B, Burns P N, Kaul S, Miller J G, Monaghan M, Porter T R, Shaw L J, Villanueva F S. Contrast echocardiography: current and future applications. J Am Soc Echocardiogr 2000; 13: 331–342, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- O'Brien W D, Jr., Simpson D G, Frizzell L A, Zachary J F. Superthreshold behavior and threshold estimates of ultrasound-induced lung hemorrhage in adult rats: role of beamwidth. IEEE Trans Ultrason Ferroelectr Freq Control 2001; 48: 1695–1705, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Ohta S, Suzuki K, Tachibana K, Yamada G. Microbubble-enhanced sonoporation: efficient gene transduction technique for chick embryos. Genesis 2003; 37: 91–101, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pan H, Zhou Y, Izadnegahdar O, Cui J, Deng C X. Study of sonoporation dynamics affected by ultrasound duty cycle. Ultrasound Med Biol 2005; 31: 849–856, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Pislaru S V, Pislaru C, Kinnick R R, Singh R, Gulati R, Greenleaf J F, Simari R D. Optimization of ultrasound-mediated gene transfer: comparison of contrast agents and ultrasound modalities. Eur Heart J 2003; 24: 1690–1698, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Porter T R, Hiser W L, Kricsfeld D, Deligonul U, Xie F, Iversen P, Radio S. Inhibition of carotid artery neointimal formation with intravenous microbubbles. Ultrasound Med Biol 2001; 27: 259–265, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Porter T R, Iversen P L, Li S, Xie F. Interaction of diagnostic ultrasound with synthetic oligonucleotide-labeled perfluorocarbon-exposed sonicated dextrose albumin microbubbles. J Ultrasound Med 1996; 15: 577–584, [PUBMED], [INFOTRIEVE], [CSA]
- Price R J, Kaul S. Contrast ultrasound targeted drug and gene delivery: an update on a new therapeutic modality. J Cardiovasc Pharmacol Ther 2002; 7: 171–180, [PUBMED], [INFOTRIEVE], [CSA]
- Price R J, Skyba D M, Kaul S, Skalak T C. Delivery of colloidal particles and red blood cells to tissue through microvessel ruptures created by targeted microbubble destruction with ultrasound. Circulation 1998; 98: 1264–1267, [PUBMED], [INFOTRIEVE], [CSA]
- Raisinghani A, De Maria A N. Physical principles of microbubble ultrasound contrast agents. Am J Cardiol 2002; 90(Suppl 10A)3J–7J, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Rychak J J, Klibanov A L, Hossack J A. Acoustic radiation force enhances targeted delivery of ultrasound contrast microbubbles: in vitro verification. IEEE Trans Ultrason Ferroelectr Freq Control 2005; 52: 421–433, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sakakima Y, Hayashi S, Yagi Y, Hayakawa A, Tachibana K, Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther 2005; 12: 884–889, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Sanders W E, Jr., Cheirif J, Desir R, Zoghbi W A, Hoyt B D, Schulz P E, Quinones M A. Contrast opacification of left ventricular myocardium following intravenous administration of sonicated albumin microspheres. Am Heart J 1991; 122: 1660–1665, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Scholz D, Ziegelhoeffer T, Helisch A, Wagner S, Friedrich C, Podzuweit T, Schaper W. Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice. J Mol Cell Cardiol 2002; 34: 775–787, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shimamura M, Sato N, Taniyama Y, Yamamoto S, Endoh M, Kurinami H, Aoki M, Ogihara T, Kaneda Y, Morishita R. Development of efficient plasmid DNA transfer into adult rat central nervous system using microbubble-enhanced ultrasound. Gene Ther 2004; 11: 1532–1539, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Shohet R V, Chen S, Zhou Y T, Wang Z, Meidell R S, Unger R H, Grayburn P A. Echocardiographic destruction of albumin microbubbles directs gene delivery to the myocardium. Circulation 2000; 101: 2554–2556, [PUBMED], [INFOTRIEVE], [CSA]
- Shortencarier M J, Dayton P A, Bloch S H, Schumann P A, Matsunaga T O, Ferrara K W. A method for radiation-force localized drug delivery using gas-filled lipospheres. IEEE Trans Ultrason Ferroelectr Freq Control 2004; 51: 822–831, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Skyba D M, Price R J, Linka A Z, Skalak T C, Kaul S. Direct in vivo visualization of intravascular destruction of microbubbles by ultrasound and its local effects on tissue. Circulation 1998; 98: 290–293, [PUBMED], [INFOTRIEVE], [CSA]
- Song J, Chappell J C, Qi M, Van Gieson E J, Kaul S, Price R J. Influence of injection site, microvascular pressure and ultrasound variables on microbubble-mediated delivery of microspheres to muscle. J Am Coll Cardiol 2002; 39: 726–731, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Song J, Cottler P S, Klibanov A L, Kaul S, Price R J. Microvascular remodeling and accelerated hyperemia blood flow restoration in arterially occluded skeletal muscle exposed to ultrasonic microbubble destruction. Am J Physiol Heart Circ Physiol 2004; 287: H2754–H2761, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Song J, Qi M, Kaul S, Price R J. Stimulation of arteriogenesis in skeletal muscle by microbubble destruction with ultrasound. Circulation 2002; 106: 1550–1555, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stride E, Saffari N. Microbubble ultrasound contrast agents: a review. Proc Inst Mech Eng [H] 2003; 217: 429–447, [CROSSREF], [CSA]
- Stride E, Saffari N. The potential for thermal damage posed by microbubble ultrasound contrast agents. Ultrasonics 2004; 42: 907–913, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Stride E, Saffari N. Theoretical and experimental investigation of the behaviour of ultrasound contrast agent particles in whole blood. Ultrasound Med Biol 2004; 30: 1495–1509, [PUBMED], [INFOTRIEVE], [CSA]
- Takalkar A M, Klibanov A L, Rychak J J, Lindner J R, Ley K. Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release 2004; 96: 473–482, [PUBMED], [INFOTRIEVE], [CSA]
- Taniyama Y, Tachibana K, Hiraoka K, Aoki M, Yamamoto S, Matsumoto K, Nakamura T, Ogihara T, Kaneda Y, Morishita R. Development of safe and efficient novel nonviral gene transfer using ultrasound: enhancement of transfection efficiency of naked plasmid DNA in skeletal muscle. Gene Ther 2002; 9: 372–380, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Taniyama Y, Tachibana K, Hiraoka K, Namba T, Yamasaki K, Hashiya N, Aoki M, Ogihara T, Yasufumi K, Morishita R. Local delivery of plasmid DNA into rat carotid artery using ultrasound. Circulation 2002; 105: 1233–1239, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tiukinhoy S D, Khan A A, Huang S, Klegerman M E, MacDonald R C, McPherson D D. Novel echogenic drug-immunoliposomes for drug delivery. Invest Radiol 2004; 39: 104–110, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Tsutsui J M, Xie F, Porter R T. The use of microbubbles to target drug delivery. Cardiovasc Ultrasound 2004; 2: 23–29, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Unger E C, Hersh E, Vannan M, Matsunaga T O, McCreery T. Local drug and gene delivery through microbubbles. Prog Cardiovasc Dis 2001; 44: 45–54, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Unger E C, Matsunaga T O, McCreery T, Schumann P, Sweitzer R, Quigley R. Therapeutic applications of microbubbles. Eur J Radiol 2002; 42: 160–168, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Unger E C, Porter T, Culp W, Labell R, Matsunaga T, Zutshi R. Therapeutic applications of lipid-coated microbubbles. Adv Drug Deliv Rev 2004; 56: 1291–1314, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- van Wamel A, Bouakaz A, Versluis M, De Jong N. Micromanipulation of endothelial cells: ultrasound-microbubble-cell interaction. Ultrasound Med Biol 2004; 30: 1255–1258, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Vannan M, McCreery T, Li P, Han Z, Unger E, Kuersten B, Nabel E, Rajagopalan S. Ultrasound-mediated transfection of canine myocardium by intravenous administration of cationic microbubble-linked plasmid DNA. J Am Soc Echocardiogr 2002; 15: 214–218, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wei K, Jayaweera A R, Firoozan S, Linka A, Skyba D M, Kaul S. Quantification of myocardial blood flow with ultrasound-induced destruction of microbubbles administered as a constant venous infusion. Circulation 1998; 97: 473–483, [PUBMED], [INFOTRIEVE], [CSA]
- Wei K, Skyba D M, Firschke C, Jayaweera A R, Lindner J R, Kaul S. Interactions between microbubbles and ultrasound: in vitro and in vivo observations. J Am Coll Cardiol 1997; 29: 1081–1088, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wu J. Temperature rise generated by ultrasound in the presence of contrast agent. Ultrasound Med Biol 1998; 24: 267–274, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wu J. Theoretical study on shear stress generated by microstreaming surrounding contrast agents attached to living cells. Ultrasound Med Biol 2002; 28: 125–129, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Wu J, Pepe J, Dewitt W. Nonlinear behaviors of contrast agents relevant to diagnostic and therapeutic applications. Ultrasound Med Biol 2003; 29: 555–562, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Yamamoto N, Kohmoto T, Gu A, De Rosa C, Smith C R, Burkhoff D. Angiogenesis is enhanced in ischemic canine myocardium by transmyocardial laser revascularization. J Am Coll Cardiol 1998; 31: 1426–1433, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhigang W, Zhiyu L, Haitao R, Hong R, Qunxia Z, Ailong H, Qi L, Chunjing Z, Hailin T, Lin G, Mingli P, Shiyu P. Ultrasound-mediated microbubble destruction enhances VEGF gene delivery to the infarcted myocardium in rats. Clin Imaging 2004; 28: 395–398, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhong P, Zhou Y, Zhu S. Dynamics of bubble oscillation in constrained media and mechanisms of vessel rupture in SWL. Ultrasound Med Biol 2001; 27: 119–134, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
- Zhou Z, Mukherjee D, Wang K, Zhou X, Tarakji K, Ellis K, Chan A W, Penn M S, Ostensen J, Thomas J D. Induction of angiogenesis in a canine model of chronic myocardial ischemia with intravenous infusion of vascular endothelial growth factor (VEGF) combined with ultrasound energy and echo contrast agent. J Am Coll Cardiol 2002; 39: 396–396, [CROSSREF], [CSA]